USP22 overexpression occurs in many cancer types, including gastric cancer [6], playing oncogenic roles via multiple mechanisms, such as the activation of transcription factors [5], the attenuation of cancer cell apoptosis [7], and promotion of the cell cycle transition [8]. Here, USP22 is linked to cancer.